Skip to main content

AT III in Pregnancy and Newborn Infants

  • Conference paper
Perinatal Thrombosis and Hemostasis
  • 69 Accesses

Abstract

Blood fluidity is determined by the balance between the components of the coagulation and fibrinolytic pathways. The balance is maintained by the activators and inhibitors of the respective proenzymes and enzymes (Fig. 1). Disturbances in either of these systems lead to thrombosis or bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gjønnaes H, Fagerhol MK (1975) Studies on coagulation and fibrinolysis in pregnancy. Acta Obstet Gynecol Scand 54: 363–367

    Article  Google Scholar 

  2. Ambrus JL, Ambrus CM, Lillie MA, Browne BJ, Hanson FW, Niswander K, Witul M, Jung DS, Bartfay-Szabo A (1976) Effects of various estrogen treatment schedules on antithrombin III levels. Commun Chemic Pathol Pharmacol 14: 543–549

    CAS  Google Scholar 

  3. Weiner CP, Brand Y (1980) Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol 56: 603–610

    Google Scholar 

  4. Hellgren M, Blomäck M (1981) Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest 13: 141 – 154

    Article  Google Scholar 

  5. Weenink GH, Treffers PE, Kahlé LH, ten Cate JW (1982) Antithrombin III in normal pregnancy. Thromb Res 26: 281–287

    Article  PubMed  CAS  Google Scholar 

  6. Villesanta U (1965) Thromboembolic disease in pregnancy. Am J Obstet Gynecol 93: 142–160

    Google Scholar 

  7. Husni EA, Pena LI, Engle-Lenhert A (1967) Thrombophlebitis in pregnancy. Am J Obstet Gynecol 97: 901–905

    PubMed  CAS  Google Scholar 

  8. Aaro LA, Juergens JC (1971) Thrombophlebitis associated with pregnancy. Am J Obstet Gynecol 109: 1128–1136

    PubMed  CAS  Google Scholar 

  9. Flessa HC, Glueck HI, Dritschilo A (1974) Thromboembolic disorders in pregnancy: pathophysiology, diagnosis, and treatment with emphasis on heparin. Clin Obstet Gynecol 17: 195–235

    Article  PubMed  CAS  Google Scholar 

  10. Hillesma V (1960) Occurrence and anticoagulant treatment of thromboembolism in gravidas, parturients and gynecologic patients. Acta Obstet Gynecol Scand (Suppl 2) 39: 5–76

    Article  Google Scholar 

  11. Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW (1980) Severe antithrombin III deficiency in a patient with pre-eclampsia. Scand J Haematol 25: 81–86

    Article  PubMed  Google Scholar 

  12. Hellgren M, Nygards E-B, Robbe H (1982) Antithrombin III in late pregnancy. Acta Obstet Gynecol Scand 61: 187–189

    Article  PubMed  CAS  Google Scholar 

  13. Schregel W, Straub H, Wölk G, Schneider R (1984) Successful treatment of massive dissiminated intravascular coagulation in EPH gestosis with multiple organ insufficiency. Anasth Intensivther Notfallmed 19: 201–203

    Article  PubMed  CAS  Google Scholar 

  14. Goubran, F, Fareed A, Elian A, Abolouz S (1985) Antithrombin III and α 2 -macroglobulin in normal pregnancy and preeclampsia. Thromb Haemost 54: 204

    Google Scholar 

  15. Friedman KD, Borok Z, Owen J (1986) Heparin cofactor activity and antithrombin III antigen levels in preeclampsia. Thromb Res 43: 409–416

    Article  PubMed  CAS  Google Scholar 

  16. Brandt P (1981) Observations during the treatment of antithrombin III deficient women with heparin and antithrombin concentrate during pregnancy, parturation and abortion. Thromb Res 22: 15–24

    Article  PubMed  CAS  Google Scholar 

  17. Handeland GF, Abildgaard U (1985) In vivo recovery of antithrombin concentrates. Thromb Res 39: 133–138

    Article  PubMed  CAS  Google Scholar 

  18. Schoch U, Zanetti E, von Feiten A (1987) Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis. Schweiz Med Wochenschr 117: 1807–1810

    PubMed  CAS  Google Scholar 

  19. De Stefano V, Leone G, de Carolis S, Ferelli R, di Donfrancesco A, Moneta E, Bizzi B (1988) Management of pregnancy in women with antithrombin III congenital defect: Report of four cases. Thromb Haemost 59: 193–196

    PubMed  Google Scholar 

  20. Jürgens H, Göbel U, Bokelmann J, von Voss H, Wahn V (1979) Coagulation studies on umbilical arterial and venous blood from normal newborn babies. Eur J Pediatr 131: 199–204

    Article  PubMed  Google Scholar 

  21. Peters M, Breederveld C, Kahlé LH, ten Cate JW (1982) Rapid microanalysis of coagulation parameters by automated chromogenic substrate methods — application in neonatal patients. Thromb Res 28: 773–781

    Article  PubMed  CAS  Google Scholar 

  22. Peters M, ten Cate JW, Koo LH, Breederveld C (1984) Persistent antithrombin III deficiency: Risk factor for thromboembolic complications in neonates small for gestational age. J Pediatr 105: 310–314

    Article  PubMed  CAS  Google Scholar 

  23. Andrew M, Pars B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P (1987) Development of the human coagulation system in the full-term infant. Blood 70: 165–172

    PubMed  CAS  Google Scholar 

  24. McDonald MM, Hathaway WE, Reeve EB, Leonard BD (1982) Biochemical and functional study of antithrombin III in newborn infants. Thromb Haemost 47: 56–58

    PubMed  CAS  Google Scholar 

  25. Peters M, Jansen E, ten Cate J, Kahlé LH, Ockelford P, Breederveld C (1984) Neonatal antithrombin III. Br J Haematol 58: 579–587

    Article  PubMed  CAS  Google Scholar 

  26. Schmidt BK, Muraji T, Zipursky A (1986) Low antithrombin III in neonatal shock: DIC or non-specific protein depletion? Eur J Pediatr 145: 500–503

    Article  PubMed  CAS  Google Scholar 

  27. Hathaway WE, Neumann LL, Borden CA, Jacobsen LJ (1978) Immunologic studies of antithrombin III heparin cofactor in the newborn. Thromb Haemost 39: 624–630

    PubMed  CAS  Google Scholar 

  28. Henriksson P, Westström G, Hedner U (1979) Umbilical artery catheterization in newborns. Acta Paediatr Scand 68: 719–723

    PubMed  CAS  Google Scholar 

  29. von Kries R, Schweickert M, Gunzelmann KH, Göbel U (1984) Antithrombin III activity and concentration in healthy and ill newborns. Lab Med 7: 353–357

    Google Scholar 

  30. Peters M, ten Cate JW, Breederveld C, de Leeuw R, Emeis J, Koppe J (1984) Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: Poor prognosis. Pediatr Res 18: 273–276

    Article  PubMed  CAS  Google Scholar 

  31. Andrew M, Massicotté-Nolan P, Mitchell L, Cassidy K (1985) Dysfunctional antithrombin III in sick premature infants. Pediatr Res 19: 237–239

    Article  PubMed  CAS  Google Scholar 

  32. Schander K, Niesen K, Rehm A, Budde U, Müller N (1980) Diagnosis and therapy of a congenital antithrombin III deficiency during the neonatal period. In: Deutsch E, Lechner K (eds) Fibrinolyse, Thrombose and Haemostase. Schattauer Verlag, Stuttgart, pp 483–486

    Google Scholar 

  33. Brenner B, Fishman A, Goldsher D, Schreibman D, Tavory S (1988) Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol 27: 209–221

    Article  PubMed  CAS  Google Scholar 

  34. Markarian M (1982) Heparin resistance in newborn infants. J Pediatr 103: 175

    Google Scholar 

  35. von Kries R, Stannigel H, Göbel U (1985) Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. Eur J Pediatr 144: 191–194

    Article  Google Scholar 

  36. Ambrus CM, Choi TS, Cunnanan E, Eisenberg B, Staub HP, Weintraub H Q (1977) Prevention of hyaline membrane disease with plasminogen. A cooperative study. JAMA 237: 1837–1841

    Article  PubMed  CAS  Google Scholar 

  37. Peters M, ten Cate JW, Jansen E, Breederveld C (1985) Coagulation and fibrinolytic factors in the first week of life in healthy infants. J Pediatr 106: 292–295

    Article  PubMed  CAS  Google Scholar 

  38. Hadnagy J, Giertler U, Halvax L, Sulyok E, Ertl T, Csaba IF, Buchenan W (1983) The antithrombin Ill-activity in the newborn age. Dtsch Gesundh Wesen 38: 1719–1720

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Japan

About this paper

Cite this paper

Karges, H.E. (1991). AT III in Pregnancy and Newborn Infants. In: Suzuki, S., Hathaway, W.E., Bonnar, J., Sutor, A.H. (eds) Perinatal Thrombosis and Hemostasis. Springer, Tokyo. https://doi.org/10.1007/978-4-431-65871-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-65871-9_6

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-65873-3

  • Online ISBN: 978-4-431-65871-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics